Lisinopril/Hydrochlorothiazide
Brand name: Lisinopril-Hydrochlorothiazide
Rank #365 of 500 drugs by total cost
$26.8M
Total Cost
2,304,445
Total Claims
$26.8M
Total Cost
59,871
Prescribers
$12
Cost per Claim
494,431
Beneficiaries
6,137,066
30-Day Fills
$448
Avg Cost/Provider
38
Avg Claims/Provider
About Lisinopril/Hydrochlorothiazide
Lisinopril/Hydrochlorothiazide (sold as Lisinopril-Hydrochlorothiazide) was prescribed 2,304,445 times by 59,871 Medicare Part D providers in 2023, costing the program $26.8M. At $12 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 362 | Memantine Hcl/Donepezil Hcl (Namzaric) | $27.2M | 46,134 |
| 363 | Solifenacin Succinate (Solifenacin Succinate) | $27.1M | 343,174 |
| 364 | Insulin Aspart (Niacinamide) (Fiasp Flextouch) | $27.0M | 24,598 |
| 365 | Lisinopril/Hydrochlorothiazide (Lisinopril-Hydrochlorothiazide) | $26.8M | 2,304,445 |
| 366 | Dofetilide (Dofetilide) | $26.7M | 98,814 |
| 367 | Plecanatide (Trulance) | $26.6M | 36,026 |
| 368 | Ursodiol (Ursodiol) | $26.6M | 123,719 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology